FCP
PFE icon

Fidelis Capital Partners’s Pfizer PFE Stock Holding History

Fidelis Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
51,883
+3,858
+8% +$101K 0.07% 199
2026
Q1 		$1.35M Sell
48,025
-14,221
-23% -$379K 0.1% 174
2025
Q4 		$1.55M Buy
62,246
+29,862
+92% +$753K 0.11% 150
2025
Q3 		$825K Buy
32,384
+5,101
+19% +$126K 0.06% 228
2025
Q2 		$653K Buy
27,283
+11,533
+73% +$269K 0.06% 231
2025
Q1 		$361K Sell
15,750
-8,768
-36% -$229K 0.04% 292
2024
Q4 		$642K Sell
24,518
-1,317
-5% -$35.7K 0.06% 220
2024
Q3 		$746K Buy
25,835
+1,267
+5% +$37K 0.09% 190
2024
Q2 		$709K Buy
24,568
+412
+2% +$11.3K 0.1% 169
2024
Q1 		$670K Buy
24,156
+4,676
+24% +$130K 0.1% 179
2023
Q4 		$561K Sell
19,480
-404
-2% -$12.2K 0.12% 157
2023
Q3 		$653K Sell
19,884
-2,607
-12% -$92.2K 0.22% 107
2023
Q2 		$825K Buy
22,491
+1,182
+6% +$46K 0.3% 78
2023
Q1 		$820K Buy
21,309
+9,356
+78% +$404K 0.35% 71
2022
Q4 		$578K Buy
+11,953
New +$573K 0.68% 48

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelis Capital Partners's PFE Position: Q2 2026 in Review

Fidelis Capital Partners increased its Pfizer (PFE) stake by 8% in Q2 2026, buying an estimated $101K and bringing the position to 51,883 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #199.

Fidelis Capital Partners first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.55M in Q4 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fidelis Capital Partners held 51,883 shares of Pfizer worth $1.25M as of Q2 2026.
  • Fidelis Capital Partners bought 3,858 Pfizer shares in Q2 2026, an estimated $101K.
  • Pfizer made up 0.07% of Fidelis Capital Partners's portfolio in Q2 2026, its #199 holding.
  • Fidelis Capital Partners first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Fidelis Capital Partners's Pfizer position peaked at $1.55M in Q4 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.